| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.021 | 0.7 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.7 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.029 | 0.7 |